GlassScriptPhysician profile
Mark R Palazzolo
NPI 1972520559
$53,557.74
in general payments reported to CMS, 2019-2025
27 companies · $3,219 in 2025
The $3,219 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,279 · 2020: $13K · 2021: $17K · 2022: $7,440 · 2023: $4,821 · 2024: $3,070 · 2025: $3,219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $10K · Food and Beverage: $1,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,056.99 |
| Food and Beverage | $1,053.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $26,934.82 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $24,219.74 | 2019-2021 | |
| Hologic Sales and Service, LLC | $641.22 | 2019-2025 | Acessa Provu System, Novasure, Coolseal Generator |
| Gynesonics, INC. | $292.49 | 2022 | |
| Abbvie INC. | $251.09 | 2019-2023 | |
| Daiichi Sankyo INC. | $142.55 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $115.35 | 2021-2023 | |
| Exeltis, USA INC. | $111.60 | 2019-2024 | Slynd |
| Astellas Pharma US INC | $97.32 | 2023-2025 | Veozah, Myrbetriq |
| Agile Therapeutics, INC. | $96.00 | 2021-2023 | Twirla |
| Therapeuticsmd, INC. | $81.40 | 2020-2022 | |
| Scynexis, INC. | $75.44 | 2022 | |
| Myovant Sciences INC. | $74.22 | 2021 | |
| Avion Pharmaceuticals | $73.74 | 2021-2022 | |
| Coopersurgical, INC. | $63.75 | 2019-2025 | Mara Console, Sos |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $51.65 | 2019-2023 | |
| Medtronic, INC. | $49.09 | 2022-2023 | Truclear |
| Optumhealth Care Solutions, LLC | $46.41 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Amag Pharmaceuticals, INC. | $27.49 | 2019-2020 | |
| Meditrina | $23.89 | 2021-2022 | |
| Biogen, INC. | $23.65 | 2025 | Zurzuvae |
| Radiometer America, INC | $16.05 | 2022 | |
| Glaxosmithkline, LLC. | $14.31 | 2022 | |
| Lupin INC. | $14.07 | 2021 | |
| Minerva Surgical, INC | $13.98 | 2025 | |
| Allotrope Medical, INC | $6.42 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Palazzolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.